What SigmaBleyzer does

SigmaBleyzer is a Houston-headquartered private equity firm founded in 1994 by Michael Bleyzer and Lev Bleyzer that manages a family of investment funds providing institutional investors and high-net-worth individuals with exposure to Eastern European and US emerging-market opportunities. The firm's fund complex includes the Ukrainian Growth Family of Funds (UGF I, II, III — $100 million raised in the mid-1990s), the SigmaBleyzer SE European Fund (SBF IV — €250 million launched in 2006, anchored by EBRD and OPIC/DFC and active in Ukraine and Romania), and the MagnaSci Family of Funds (launched 2016 for US early-stage biotechnology). Through these vehicles and co-investment opportunities (including geographically targeted vehicles such as Kazakhstan), SigmaBleyzer has deployed approximately $1 billion of capital across more than 100 companies and realized over 90 exits spanning agriculture, cable and media, confectionery, dairy, pharmaceutical retail and shipbuilding. Operational offices in Kyiv and Kharkiv (since 1994) and a Houston back-office serving 100+ LPs across the United States, Europe, Middle East and South America provide the dual Western capital and local Eastern European presence that the firm positions as its core differentiator.

The firm earns revenue through conventional private equity economics — management fees on committed or invested fund capital plus carried interest on realized gains — supplemented by an advisory services practice that provides management consulting to local and international firms navigating the Ukrainian and Eastern European business environment. Distribution is entirely direct, with no intermediaries, relying on the investor relations team in Houston and partner-level relationships with institutional LPs. Beyond funds and advisory, SigmaBleyzer maintains an impact and advocacy arm through affiliated nonprofits (The Bleyzer Foundation, Daar Foundation, Dar Ukraine, and Ukraine Rises) that conduct economic policy research, charitable programs and frontline humanitarian aid in Ukraine. Leadership includes founding partners, senior partner Neal Sigda (Investment Committee chair), partner Ryan O'Malley (CFO of MagnaSci and head of the Houston office), partner Jessica Bleyzer (strategic initiatives), and Ukraine-based directors Vadim Bodaev (Government Affairs) and Yuriy Davydov (Internal Controls), with backgrounds combining Western finance and consulting experience with deep regional and cultural expertise.

Name

SigmaBleyzer

Legal name

SigmaBleyzer Investment Group, LLC

Website

https://sigmableyzer.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

SigmaBleyzer is a Houston-headquartered private equity firm founded in 1994 that manages a family of funds investing across Eastern Europe, primarily Ukraine, and US biotechnology, serving institutional and high-net-worth investors with on-the-ground operational value creation.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Vehicles (52599)

SIC

Investment Advice (6282), Services-Management Consulting Services (8742)

akta.pro primary industry

Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE)

akta.pro secondary industry

Alternative Investments for Private Wealth (Hedge Funds, PE/VC Access, Private Credit) (FSAAABAI)

Keywords

• Private equity funds
• Emerging market investing
• Investment management services
• Biotechnology venture capital
• Management consulting

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Private Equity Fund Management: SigmaBleyzer generates revenue through management fees and carried interest (performance fees) from its family of private equity funds. The firm provides institutional investors and high-net-worth individuals access to unique investment opportunities in Eastern Europe, primarily Ukraine, through its UGF, SBF IV, MagnaSci, and co-investment vehicles.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

SigmaBleyzer is a private equity firm that manages a family of private equity funds (Ukrainian Growth Family of Funds, SBF IV, MagnaSci) and co-investment vehicles, providing institutional investors and high-net-worth individuals access to emerging market private equity opportunities in Eastern Europe (primarily Ukraine and Romania) and US biotechnology ventures. The firm also offers management consulting and advisory services to local and international firms seeking to navigate business environments in Ukraine and Eastern Europe. Revenue is generated through fund management fees and carried interest on capital under management.

Product overview

SigmaBleyzer is a private equity and investment management firm offering a portfolio of investment fund products alongside advisory services and impact initiatives. The core investment products include the Ukrainian Growth Family of Funds (UGF I, II, III) for Ukrainian market exposure, the SigmaBleyzer SE European Fund (SBF IV) for Romania and Ukraine buyouts, and the MagnaSci Family of Funds for US biotechnology ventures. The firm also offers co-investment opportunities and is launching a new fund for post-war Ukraine reconstruction. Supporting services include institutional-quality back-office operations (investor relations, accounting, tax, reporting) and management consulting advisory services. The firm's impact arm includes affiliated nonprofits: Dar Ukraine, Daar Foundation, Ukraine Rises, and The Bleyzer Foundation, which collectively provide humanitarian aid and support economic development in Eastern Europe.

Differentiator

Problem solved

Functional benefit

Products and services

• Ukrainian Growth Family of Funds (UGF I, II, III) A family of private equity funds launched in the mid-1990s with $100 million in capital, investing in Ukrainian companies through diversified portfolio strategies and later shifting to focus on majority-owned private equity buyouts. Targeted at institutional investors and high-net-worth individuals seeking exposure to the Ukrainian emerging market.
• SigmaBleyzer SE European Fund (SBF IV) A €250 million private equity buyout fund launched in 2006, investing in Ukraine and Romania across cable, agriculture, pharmaceutical retail, and dairy production sectors, consolidating multiple companies to create market leaders. Backed by EBRD, OPIC (now DFC), and numerous institutional investors.
• MagnaSci Family of Funds A biotechnology-focused family of funds launched in 2016, combining venture investment with operational involvement to reduce early-stage biotech risk. The funds primarily target minority investments in US-based early-stage biotech, life science, and healthcare ventures ahead of FDA Phase 2 development.
• Co-investment Opportunities Customized co-investment opportunities offered alongside core funds, enabling investors to participate in specific deals across various sectors including general partner stakes, reinvestment vehicles, and geographically targeted funds such as Kazakhstan.
• New Ukraine Reconstruction Fund An upcoming private equity fund focused on identifying attractive investment opportunities in post-war Ukraine, concentrating on restructuring opportunities and value creation through growth and development.
• Advisory Services Management consulting and advisory services leveraging over 25 years of operational and investment experience in Ukraine and Eastern Europe, providing local market expertise combined with Western business practices to local and international firms seeking to navigate the region's complex business environment, pursue growth, or restructure operations.

Quantifiable outcome

• ~$1 billion invested across 100+ companies with 90+ exits since 1994
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered major, core and minor.

• Daar FoundationmajorStrategic or Co-development Partner · 1 January 2004US-based nonprofit with 20-year history of charitable work in Ukraine, originally focused on disadvantaged youth and Ukrainian cultural projects. Shifted in 2014 to provide frontline assistance and has mobilized for large-scale humanitarian aid in partnership with Dar Ukraine.
• Dar UkrainemajorStrategic or Co-development Partner · 1 January 1998Ukrainian affiliate nonprofit (registered 2006) that evolved from helping children and supporting Ukrainian culture to distributing humanitarian aid throughout Ukraine including the front lines. Founded in 1998, Dar Ukraine is the heart of SigmaBleyzer's impact work.
• The Bleyzer FoundationcoreStrategic or Co-development PartnerAffiliated nonprofit foundation advocating open market economies, transparency, business liberalization, and honest government-business partnerships. Supports creation of stable, predictable business conditions for private-sector-led economic growth in emerging markets.
• Ukraine RisesminorStrategic or Co-development PartnerNonprofit focused on helping Ukrainians reclaim their lives, rebuild their nation, and restore hope in a more prosperous future. Committed to redevelopment of a sovereign, democratic, and prosperous Ukraine in areas of health/safety, economic resilience, and truth/advocacy.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Horizon Capital: Horizon Capital is a Ukraine-focused private equity firm (successor to Western NIS Enterprise Fund) investing in Ukrainian and Moldovan growth and buyout deals. It is the most direct comparable to SigmaBleyzer in terms of geographic focus, fund strategy, and LP base, although it is generally larger in current AUM.
• Dragon Capital: Dragon Capital is a leading Ukrainian investment firm offering private equity, asset management, and brokerage services. It is directly comparable to SigmaBleyzer's Ukraine-focused PE and advisory activities, with overlapping LP relationships and competing for the same portfolio companies.
• East Capital: East Capital is a Stockholm-based asset manager specializing in Emerging Europe and frontier markets, with PE and public equity strategies. It is comparable to SigmaBleyzer's Eastern European PE focus and LP base, though it covers a broader geographic footprint than Ukraine alone.
• Actis: Actis is a global emerging-markets private equity and infrastructure firm with significant historical exposure to Eastern Europe and Africa. It is comparable to SigmaBleyzer's emerging-market PE strategy and institutional LP base, particularly through EBRD-type co-investments in regional buyouts.

Regional players

• ICU Group: ICU is a Ukraine-based asset manager, investment adviser, and PE participant focused on Ukrainian and Eastern European opportunities. It is comparable to SigmaBleyzer's regional investment-advisory and PE business, though it is more diversified across fixed income and equities.
• Concorde Capital (Ukraine): Concorde Capital is a Ukraine-based investment firm active in investment banking, asset management, and private equity. It is comparable to SigmaBleyzer's regional investment-advisory and deal-sourcing activities in Ukraine, though it is more weighted toward capital markets and advisory services.

Broad incumbents

• Advent International: Advent International is a global private equity firm with Central and Eastern European exposure through its regional buyout funds. It competes with SigmaBleyzer for institutional LP capital and large-cap regional deals, but at materially larger scale and with a global portfolio.
• KKR: KKR is a global alternative asset manager with established emerging-markets and European PE operations. It is comparable to SigmaBleyzer's larger institutional peers competing for capital outflows from emerging markets, though its scale and product breadth are vastly larger.
• The Carlyle Group: The Carlyle Group is a global alternative asset manager with deep European and emerging-markets PE exposure. It is comparable to SigmaBleyzer at the high end of the institutional LP universe but operates at significantly greater scale and product diversification.

Emerging players

• Affirma Capital (formerly Standard Chartered PE): Affirma Capital is an emerging-markets private equity firm with a long history of investments in Asia, Africa, the Middle East, and Eastern Europe. It is comparable to SigmaBleyzer's emerging-market PE mandate and institutional fundraising approach, though its geographic focus is broader.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SigmaBleyzer